Indication
Intra-abdominal E. coli abscess
An intra-abdominal *Escherichia coli* abscess is a localized, walled-off collection of purulent exudate, necrotic debris, and microorganisms within the peritoneal cavity, retroperitoneum, or visceral abdominal organs, caused in whole or in part by the Gram-negative bacillus *E. Read more about Intra-abdominal E. coli abscess
37 drugs 33 manufacturers
Drugs that treat it
Common Intra-abdominal E. coli abscess therapies.
MEFOXIN IN DEXTROSE (ISO-OSM) (cefoxitin sodium/dextrose 5 % in water)
UNASYN (ampicillin sodium/sulbactam sodium)
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
CEFOXITIN SODIUM (cefoxitin sodium/dextrose, iso-osmotic)
CEFOXITIN (cefoxitin sodium)
CEFOXITIN (cefoxitin sodium)
CEFOXITIN (cefoxitin sodium)
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAn intra-abdominal *Escherichia coli* abscess is a localized, walled-off collection of purulent exudate, necrotic debris, and microorganisms within the peritoneal cavity, retroperitoneum, or visceral abdominal organs, caused in whole or in part by the Gram-negative bacillus *E.
coli*.
It typically arises as a complicated intra-abdominal infection following gastrointestinal mucosal disruption, viscera perforation (such as appendicitis or diverticulitis), penetrating trauma, or postoperative anastomotic dehiscence.
Pathophysiologically, endotoxin-producing facultative anaerobes like *E.
coli* drive early acute peritonitis and localized tissue destruction, stimulating fibrin deposition and inflammatory encapsulation to contain the infection.
Clinically, affected patients present with localized or diffuse abdominal pain, persistent fever, leukocytosis, and features of systemic inflammation, with potential progression to sepsis if drainage and targeted antimicrobial therapy are delayed.
- nih.gov
An intra-abdominal *Escherichia coli* abscess is a localized, walled-off collection of purulent exudate, necrotic debris, and microorganisms within the peritoneal cavity, retroperitoneum, or visceral abdominal organs, caused in whole or in part by the Gram-negative bacillus *E. coli* It typically arises as a complicated intra-abdominal infection following gastrointestinal mucosal disruption, viscera perforation (such as appendicitis or diverticulitis), penetrating trauma, or postoperative anasto...
- nih.gov
An intra-abdominal *Escherichia coli* abscess is a localized, walled-off collection of purulent exudate, necrotic debris, and microorganisms within the peritoneal cavity, retroperitoneum, or visceral abdominal organs, caused in whole or in part by the Gram-negative bacillus *E. coli* Clinically, affected patients present with localized or diffuse abdominal pain, persistent fever, leukocytosis, and features of systemic inflammation, with potential progression to sepsis if drainage and targeted an...
- nih.gov
An intra-abdominal *Escherichia coli* abscess is a localized, walled-off collection of purulent exudate, necrotic debris, and microorganisms within the peritoneal cavity, retroperitoneum, or visceral abdominal organs, caused in whole or in part by the Gram-negative bacillus *E. coli*
- fda.gov
It typically arises as a complicated intra-abdominal infection following gastrointestinal mucosal disruption, viscera perforation (such as appendicitis or diverticulitis), penetrating trauma, or postoperative anastomotic dehiscence
- nih.gov
Pathophysiologically, endotoxin-producing facultative anaerobes like *E. coli* drive early acute peritonitis and localized tissue destruction, stimulating fibrin deposition and inflammatory encapsulation to contain the infection
Personalize your experience
Follow Intra-abdominal E. coli abscess and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.